It is a privilege to be hosted at the Polar Institute at the Wilson Center, at the heart of US law and policy at Federal ...

Delivered 250 years ago, the famous oration marked the height of Henry's influence. But the politician also served in key ...

Astronaut Edgar Dean Mitchell's experience in space led him to found the Institute of Noetic Sciences, which explores the science behind psychic and spiritual phenomena.

NORTHAMPTON— Four distinguished leaders in the arts, academia, health and wellness, social justice and innovation will be ...

For centuries, scholars have struggled to find a satisfying ... Archaeologist Melinda Zeder of the Smithsonian Institution’s National Museum of Natural History argues that settlements such ...

Scholar Rock (SRRK) announced that new efficacy and safety data from the Phase 3 pivotal SAPPHIRE trial will be presented in multiple clinical presentations at the 2025 Muscular Dystrophy ...

Primary endpoint showed clinically meaningful improvement in patients with SMA receiving apitegromab as measured by gold standard Hammersmith Functional Motor Scale Expanded (HFMSE) versus placebo ...

Scholar Rock believes that its highly selective targeting of pro- and latent forms of myostatin with apitegromab may lead to a clinically meaningful improvement in motor function in patients with SMA.

Scholar Rock’s stock is due to drop by 7.49% following the news, according to pre-market estimates. CAMBRIDGE, Mass., March 16, 2025--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical ...

Primary endpoint showed clinically meaningful improvement in patients with SMA receiving apitegromab as measured by gold standard Hammersmith Functional Motor Scale Expanded (HFMSE) versus placebo ...

Shares in Scholar Rock have gone into overdrive after the biotech reported positive phase 3 results with apitegromab in patients with spinal muscular atrophy (SMA), setting up regulatory filings ...